Maintenance treatment in depression: The role of pharmacological and psychological treatment

Current Opinion in Psychiatry

Volumn 15, Issue 1, 2002, Pages 63-68

  Winkler, Dietmar ^a   Tauscher, Johannes ^a   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MILNACIPRAN; MIRTAZAPINE; NEFAZODONE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; VENLAFAXINE;

DEPRESSION; DISABILITY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; PRIMARY HEALTH CARE; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; REVIEW;

EID: 0036146998     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200201000-00011     Document Type: Review

References (64)

1. Recurrence after recovery from major depressive disorder during 15 years of observational follow up
2. Course of depression in adults: Treatment options
3. The effect of treatment on the two-year course of late-life depression
4. Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?
5. The influence of psychopathology, personality, and marital interaction on the short-term course of major depression
6. Time to recovery, chronicity and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects
7. Strategies and tactics in the treatment of chronic depression
8. Rapid cycling and depression
9. Low-intensity treatment of depression in primary care: Is it problematic?
10. Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
11. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?
12. Long-term prognosis of depression in primary care
13. Poor prognosis of depression in elderly people: Causes and actions
14. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression
15. Maintenance desipramine for dysthymia: A placebo-controlled study
16. Sertraline versus imipramine to prevent relapse in chronic depression
17. Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly
18. Prophylactic effect of citalopram in unipolar, recurrent depression: Placebo-controlled study of maintenance therapy
19. Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
20. Does mirtazapine enhance serotonergic neurotransmission in depressed patients?
21. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium
22. Long-term treatment of geropsychiatric depressed patients with venlafaxine
23. Efficacy of venlafaxine and placebo during long-term treatment of depression: A pooled analysis of relapse rates
24. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression
25. Mirtazapine versus amitriptyline in the long-term treatment of depression: A double-blind placebo-controlled study
26. The pitfalls of long-term treatment of depression
27. Redefining antidepressant efficacy toward long-term recovery
28. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression
29. Long-term treatment of depression with nefazodone
30. Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients
31. Reboxetine in the maintenance therapy of depressive disorder in the elderly: A long-term open study
32. Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder
33. Lithium in unipolar depression and the prevention of suicide
34. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression
35. Does lithium treatment still work? Evidence of stable responses over three decades
36. Efficacy of lithium in mania and maintenance therapy of bipolar disorder
37. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders
38. Reduced suicide risk during lithium maintenance treatment
39. Is there a loss of efficacy of lithium in patients treated for over 20 years?
40. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
41. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm
42. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder
43. Who should benefit from long-term antidepressant therapy?
44. Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders
45. Pharmacotherapy of depression and mixed states in bipolar disorder
46. Bipolar disorder therapeutics; maintenance treatment
47. Clinical issues in long-term treatment with antidepressants
48. Recurrent unipolar depression requires prolonged treatment
49. Limitations to enhancing the speed of onset of antidepressants: Are rapid action antidepressants possible?
50. Possible neurobiological mechanisms underlying faster onset of antidepressant action
51. Somatic treatment of psychotic depression: Review and recommendations for practice
52. Two-year outcome of psychotic depression in late life
53. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression
54. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
55. A randomized trial of relapse prevention of depression in primary care
56. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months
57. The London depression intervention trial. Randomised controlled trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner: Clinical outcome and costs
58. Preventing recurrent depression using cognitive therapy with and without a continuation phase: A randomized clinical trial
59. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
60. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients
61. Relapse prevention in major depressive disorder after successful ECT: A literature review and a naturalistic case series
62. Extended continuation and maintenance ECT for long-lasting episodes of major depression
63. Maintenance electroconvulsive therapy in affective and schizoaffective disorder
64. Lost human capital from early-onset chronic depression